AK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base

Bulletin Express

Jun 03

AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.

Including the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.

All repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.

Under Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1174436460"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1174436460\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1174436460?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 21:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174436460","market":"us","top_or_hot":-1,"title":"AK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base","media":"Bulletin Express","content":"<p>AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.</p>\n<p>Including the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.</p>\n<p>All repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.</p>\n<p>Under Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.</p>\n<p>Including the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.</p>\n<p>All repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.</p>\n<p>Under Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"爱康医疗","start_time":0,"source_url":"","article_id":"1174436460","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174436460","pubTimestamp":1780491912,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗"},"translate_title":"爱康医疗625万港元回购109万股累计回购升至授权基数11.19%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":1},"content_text":"AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.\nIncluding the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.\nAll repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.\nUnder Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}